2017 韩国肠易激综合征临床实践指南(修订版)

2018-04-01 韩国神经胃肠病学与动力学会 J Neurogastroenterol Motil. 2018 Apr 30;24(2):197-

2018年4月,韩国神经胃肠病学与动力学会(KSNM)发布了肠易激综合征临床实践指南2017修订版,肠易激综合征是一种常见的功能性胃肠疾病,本文是对KSNM2011年发布了肠易激综合征管理指南的更新,主要包括4个主题内容,分别为肠镜检查,饮食干预,益生菌和利福昔明的应用。

中文标题:

2017 韩国肠易激综合征临床实践指南(修订版)

英文标题:

Clinical Practice Guidelines for Irritable Bowel Syndrome in Korea, 2017 Revised Edition.

发布日期:

2018-04-01

简要介绍:

2018年4月,韩国神经胃肠病学与动力学会(KSNM)发布了肠易激综合征临床实践指南2017修订版,肠易激综合征是一种常见的功能性胃肠疾病,本文是对KSNM2011年发布了肠易激综合征管理指南的更新,主要包括4个主题内容,分别为肠镜检查,饮食干预,益生菌和利福昔明的应用。

 

拓展指南:肠易激综合征相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2017 韩国肠易激综合征临床实践指南(修订版))] GetToolGuiderByIdResponse(projectId=1, id=24ce31c0015e6721, title=2017 韩国肠易激综合征临床实践指南(修订版), enTitle=Clinical Practice Guidelines for Irritable Bowel Syndrome in Korea, 2017 Revised Edition., guiderFrom=J Neurogastroenterol Motil. 2018 Apr 30;24(2):197-, authorId=null, author=, summary=2018年4月,韩国神经胃肠病学与动力学会(KSNM)发布了肠易激综合征临床实践指南2017修订版,肠易激综合征是一种常见的功能性胃肠疾病,本文是对KSNM2011年发布了肠易激综合征管理指南的更新,主要包括4个主题内容,分别为肠镜检查,饮食干预,益生菌和利福昔明的应用。 , cover=, journalId=null, articlesId=null, associationId=1626, associationName=韩国神经胃肠病学与动力学会, associationIntro=, copyright=0, guiderPublishedTime=Sun Apr 01 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>2018年4月,韩国神经胃肠病学与动力学会(KSNM)发布了肠易激综合征临床实践指南2017修订版,肠易激综合征是一种常见的功能性胃肠疾病,本文是对KSNM2011年发布了肠易激综合征管理指南的更新,主要包括4个主题内容,分别为肠镜检查,饮食干预,益生菌和利福昔明的应用。</P> <P> </P>拓展指南:<STRONG>与<FONT color=red>肠易激综合征</FONT>相关指南:</STRONG><BR> <UL> <LI><A title="2017 香港共识声明:成人肠易激综合征的治疗现况" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=1cb491c00153209b">2017 香港共识声明:成人肠易激综合征的治疗现况</A> <LI><A title=肠易激综合征中医诊疗专家共识意见(2017) target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=0837f1c0015010bc">肠易激综合征中医诊疗专家共识意见(2017)</A> <LI><A title="2017 DSGH国家指南:肠易激综合征的诊断和治疗" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=7d3ae1c001a908c5">2017 DSGH国家指南:肠易激综合征的诊断和治疗</A> <LI><A title=2017专家共识报告:优化应用利那洛肽治疗便秘型肠易激综合征 target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=a977f1c001ae9143">2017专家共识报告:优化应用利那洛肽治疗便秘型肠易激综合征</A> <LI><A title="2017 专家共识报告:优化应用利那洛肽治疗便秘型肠易激综合征" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=e16701c0013512c4">2017 专家共识报告:优化应用利那洛肽治疗便秘型肠易激综合征</A> 更多信息请点击:<A target=_blank href="http://www.medsci.cn/guideline/list.do?q=%E8%82%A0%E6%98%93%E6%BF%80%E7%BB%BC%E5%90%88%E5%BE%81">有关肠易激综合征更多指南</A></LI></UL>, tagList=[TagDto(tagId=594, tagName=肠易激综合征)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=4, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6097, appHits=211, showAppHits=5, pcHits=4184, showPcHits=2272, likes=129, shares=8, comments=20, approvalStatus=1, publishedTime=Sat Apr 07 23:14:02 CST 2018, publishedTimeString=2018-04-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Apr 07 23:14:02 CST 2018, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 16:38:18 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 韩国肠易激综合征临床实践指南(修订版))])
2017 韩国肠易激综合征临床实践指南(修订版)
下载请点击:
评论区 (20)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=304346, encodeId=a2e430434601, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Tue Apr 10 05:55:48 CST 2018, time=2018-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304170, encodeId=47b73041e0fd, content=谢谢分享学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Mon Apr 09 09:18:29 CST 2018, time=2018-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304052, encodeId=89a530405220, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Mon Apr 09 05:59:12 CST 2018, time=2018-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=303855, encodeId=85f930385545, content=好文献.新思路, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sun Apr 08 10:05:41 CST 2018, time=2018-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=303835, encodeId=00d0303835e5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/11/eb1f237032e0bf07b10833fc3722e645.jpg, createdBy=2fed2145219, createdName=紫迎馨, createdTime=Sun Apr 08 08:06:17 CST 2018, time=2018-04-08, status=1, ipAttribution=)]
    2018-04-10 秀红

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=304346, encodeId=a2e430434601, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Tue Apr 10 05:55:48 CST 2018, time=2018-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304170, encodeId=47b73041e0fd, content=谢谢分享学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Mon Apr 09 09:18:29 CST 2018, time=2018-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304052, encodeId=89a530405220, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Mon Apr 09 05:59:12 CST 2018, time=2018-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=303855, encodeId=85f930385545, content=好文献.新思路, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sun Apr 08 10:05:41 CST 2018, time=2018-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=303835, encodeId=00d0303835e5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/11/eb1f237032e0bf07b10833fc3722e645.jpg, createdBy=2fed2145219, createdName=紫迎馨, createdTime=Sun Apr 08 08:06:17 CST 2018, time=2018-04-08, status=1, ipAttribution=)]
    2018-04-09 戒馋,懒,贪

    谢谢分享学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=304346, encodeId=a2e430434601, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Tue Apr 10 05:55:48 CST 2018, time=2018-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304170, encodeId=47b73041e0fd, content=谢谢分享学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Mon Apr 09 09:18:29 CST 2018, time=2018-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304052, encodeId=89a530405220, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Mon Apr 09 05:59:12 CST 2018, time=2018-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=303855, encodeId=85f930385545, content=好文献.新思路, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sun Apr 08 10:05:41 CST 2018, time=2018-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=303835, encodeId=00d0303835e5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/11/eb1f237032e0bf07b10833fc3722e645.jpg, createdBy=2fed2145219, createdName=紫迎馨, createdTime=Sun Apr 08 08:06:17 CST 2018, time=2018-04-08, status=1, ipAttribution=)]
    2018-04-09 秀红

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=304346, encodeId=a2e430434601, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Tue Apr 10 05:55:48 CST 2018, time=2018-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304170, encodeId=47b73041e0fd, content=谢谢分享学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Mon Apr 09 09:18:29 CST 2018, time=2018-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304052, encodeId=89a530405220, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Mon Apr 09 05:59:12 CST 2018, time=2018-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=303855, encodeId=85f930385545, content=好文献.新思路, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sun Apr 08 10:05:41 CST 2018, time=2018-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=303835, encodeId=00d0303835e5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/11/eb1f237032e0bf07b10833fc3722e645.jpg, createdBy=2fed2145219, createdName=紫迎馨, createdTime=Sun Apr 08 08:06:17 CST 2018, time=2018-04-08, status=1, ipAttribution=)]
    2018-04-08 张新亮1853311252142e2fm

    好文献.新思路

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=304346, encodeId=a2e430434601, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Tue Apr 10 05:55:48 CST 2018, time=2018-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304170, encodeId=47b73041e0fd, content=谢谢分享学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Mon Apr 09 09:18:29 CST 2018, time=2018-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304052, encodeId=89a530405220, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Mon Apr 09 05:59:12 CST 2018, time=2018-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=303855, encodeId=85f930385545, content=好文献.新思路, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sun Apr 08 10:05:41 CST 2018, time=2018-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=303835, encodeId=00d0303835e5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/11/eb1f237032e0bf07b10833fc3722e645.jpg, createdBy=2fed2145219, createdName=紫迎馨, createdTime=Sun Apr 08 08:06:17 CST 2018, time=2018-04-08, status=1, ipAttribution=)]
    2018-04-08 紫迎馨

    学习了

    0